Healthcare Science Week celebrates biomedical profession
David Wells, CEO of the IBMS, discusses the Institute’s plans to ensure the future of biomedical science careers
David Wells, CEO of the IBMS, discusses the Institute’s plans to ensure the future of biomedical science careers
Leveraging Quanterix’s Simoa platform, researchers lay the groundwork for pre-symptomatic Alzheimers diagnosis, guided treatment, and accelerated clinical drug trials
Examine the benefits and logistics of transitioning your program from traditional site-based blood collection to remote sampling
Dr. Julienne Carstens highlights the critical role of spatial biology in understanding the metastatic progression of PDAC and advancing personalized immunotherapy
In this guest editorial, discover how Capitainer® DBS cards with qDBS technology enable easy self-sampling with precision and accuracy
With the QIAGEN nanoplate-based dPCR system, clinical scientists find better ways to diagnose invasive fungal disease and side-step antifungal therapy resistance
Experts discuss the game-changing potential of novel host response-based diagnostics to combat the global challenge of antimicrobial resistance (AMR)
Portable testing platforms are set to drive precision medicine and community health into 2024, so when will they see a more widespread adoption amongst healthcare providers and individuals alike?
Tell us which new products have had the biggest impact on your lab work for a chance to win a $500 Amazon.com Gift Card (or equivalent currency)
Learn how quantitative DBS technology could transform the clinical utility of dried blood spots and help drive the shift to self-sampling in healthcare
Discover how researchers at Weill Cornell Medical College are using immunoproteomics to identify biomarkers that help better understand and manage diabetic infections
Learn how researchers are using innovative gene editing techniques to uncover new drug targets
Could stronger collaboration from lab-to-frontline care be the key to advancing antimicrobial stewardship (AMS)?
Learn about the latest developments in cancer research with fellow scientists, manufacturers, and regulatory experts
Discover how a rapid diagnosis between viral and bacterial pulmonary infections can minimize antibiotic usage in critical care
Discover how a smartphone-based diagnostic platform is democratizing point-of-care testing away from the clinic into a home testing setting
Jeff Jensen, CEO of Fluxion Biosciences, describes how microfluidics technology fuels advances in drug discovery through physiologically relevant cell-based assays
With the help of Bio-Rad’s ultra-sensitive, multiplexed digital PCR system, Biodesix and its research partners are pursuing novel blood tests for the early detection and targeted treatment of lung cancer
Explore the concerted effort healthcare professionals, pharma, and biotech are making to combat cervical cancer through the development and implementation of new HPV assays
Study shows accessible blood-biomarker insights and online coaching substantially improve health indicators
Director of Laboratory Services shares how the right quality control materials can help to improve the accuracy, efficiency, and reliability of patient diagnostics in the clinical lab
How is globalization impacting the transmission of infectious diseases and what response is required from global health networks for greater security?
New fever diagnostics tool can distinguish between bacterial and viral fever, improving patient care and potentially reducing morbidity and mortality rates
Fapon’s new Shine i8000/9000 CLIA analyzer caters to high-volume clinical testing needs, while the company is also scaling up efforts to bring advanced cancer therapies to market
A new era of fast, accurate, clinical diagnostics and disease surveillance emerges from pandemic saliva testing